Skip to content

Jing Ping Yeo

Vice President, Head of Asia Pacific

Jing Ping has over 25 years of experience in Clinical Research in the Pharmaceutical and CRO industries. She brings with her a wealth of experience in all aspects of clinical development, including strategic planning, budget management, clinical operations, project management, biometrics, medical writing, medical affairs, quality management, audits, biobanking, compliance, research integrity, and ethics. In her current role, Jing Ping is responsible for Cytel’s growth strategy for Asia, servicing as the commercial and operational lead in executing the growth of Cytel’s biometrics business across software and services. 

Prior to joining Cytel, Jing Ping was the Director for Research Integrity, Compliance and Ethics in Singapore Health Services (SingHealth), the largest healthcare group of hospitals, specialty centers and primary care clinics in Singapore.  She was responsible for implementation of ethical foundations, regulatory compliance, research integrity, Good Clinical Practice and other research excellence standards for all aspects of human research within SingHealth. Before joining SingHealth, Jing Ping was the Corporate Vice President for PAREXEL International CRO, and was responsible for leading the global biopharmaceutical unit in project delivery for pharmaceutical companies and for providing strategic consultancy. She successfully led the strategic partnership program and managed portfolios of compounds from more than 50 biopharmaceutical companies.

Jing Ping is currently the Steering Committee Member for the Singapore Chapter of Drug Information Association, Program Committee for the Asia Chapter of Drug Information Association. She has been the chairperson of the Singapore Clinical Research Professional Forum until 2018 and is an active speaker in academic platforms and in pharmaceutical and CRO industries. 

Contact Us

or leave feedback